Silexion Therapeutics Corp. (SLXN)
0.2146
-0.02
(-8.64%)
USD |
NASDAQ |
Oct 09, 16:00
0.204
-0.01
(-4.94%)
After-Hours: 20:00
Silexion Therapeutics Shareholders Equity (Quarterly) : 0.044M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.044M |
| March 31, 2026 | 0.291M |
| December 31, 2025 | 2.603M |
| September 30, 2025 | 6.977M |
| June 30, 2025 | 0.12M |
| March 31, 2025 | 2.586M |
| December 31, 2024 | -3.989M |
| September 30, 2024 | -4.579M |
| June 30, 2024 | 2.538M |
| March 31, 2024 | 2.649M |
| December 31, 2023 | -0.419M |
| September 30, 2023 | 3.136M |
| Date | Value |
|---|---|
| June 30, 2023 | 25.22M |
| March 31, 2023 | 25.05M |
| December 31, 2022 | 115.49M |
| September 30, 2022 | 114.99M |
| June 30, 2022 | 114.70M |
| March 31, 2022 | 114.66M |
| December 31, 2021 | 114.91M |
| September 30, 2021 | 115.15M |
| June 30, 2021 | 115.37M |
| March 31, 2021 | 115.56M |
| December 31, 2020 | -0.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 13.77M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Eocene Ltd. | 12.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.246M |
| Total Liabilities (Quarterly) | 4.202M |
| Debt to Equity Ratio | 32.05 |
| Current Ratio | 0.9409 |
| Net Debt Paydown Yield | 13.77% |